These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1081740)

  • 1. [T and B lymphocytes. I. Assessment in leukaemia and lymphoma (author's transl)].
    Jamra M; Pozzi DH; Musatti CC; Tolnai ME; Figueiredo Mendes N
    Sangre (Barc); 1975; 20(3):273-87. PubMed ID: 1081740
    [No Abstract]   [Full Text] [Related]  

  • 2. [T and b lymphocytes. II. Sequential valuation in the course of leukaemia and lymphoma (author's transl)].
    Pozzi DH; Jamra M; Musatti CC; Tolnai ME; Figueiredo Mendes N
    Sangre (Barc); 1975; 20(3):311-22. PubMed ID: 1081741
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical, cytological and immunological analysis of T-cell type lymphoid malignancies: a classification of T-cell type lymphoid malignancy (author's transl)].
    Shimoyama M; Minato K
    Rinsho Ketsueki; 1979 Sep; 20(9):1056-69. PubMed ID: 316018
    [No Abstract]   [Full Text] [Related]  

  • 4. [T-cell lymphoma (author's transl)].
    Pathouli C; Michlmayr G; Huber C; Kurz R; Haas H; Huber H; Braunsteiner H
    Wien Klin Wochenschr; 1977 Jan; 89(2):45-9. PubMed ID: 139029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell and B-cell identification in the diagnosis of lymphoproliferative disease. A review.
    Whiteside TL; Rowlands DT
    Am J Pathol; 1977 Sep; 88(3):754-92. PubMed ID: 329685
    [No Abstract]   [Full Text] [Related]  

  • 6. [A study of non-Hodgkin's lymphoma (author's transl)].
    Kotoo Y
    Fukuoka Igaku Zasshi; 1978 Feb; 69(2):73-82. PubMed ID: 306366
    [No Abstract]   [Full Text] [Related]  

  • 7. [Non Hodgkin lymphoma of the so-called primary neuraxis type. Immunological study of 4 cases (author's transl)].
    Chazot G; Pialat J; Touraine F; Trillet M; Schott B
    Rev Neurol (Paris); 1981; 137(4):291-5. PubMed ID: 6974385
    [No Abstract]   [Full Text] [Related]  

  • 8. [The cellular immunological status as a prognostic factor in non-Hodgkin lymphomas].
    García-Puche JL; Pérez-Alférez N; Muñóz E; Garrido F; Osorio C
    Rev Clin Esp; 1975 Jul; 138(2):163-8. PubMed ID: 1080867
    [No Abstract]   [Full Text] [Related]  

  • 9. [Surface markers and clinico-pathological characteristics of lymphoproliferative malignancies (author's transl)].
    Minato K; Shimoyama M
    Rinsho Byori; 1978; 26(3):194-200. PubMed ID: 306459
    [No Abstract]   [Full Text] [Related]  

  • 10. [Classification of leukemic cells with immunologic markers].
    Shimoyama M; Minato K
    Nihon Rinsho; 1980 Aug; 38(8):2999-3017. PubMed ID: 7009921
    [No Abstract]   [Full Text] [Related]  

  • 11. Childhood lymphoblastic lymphoma, a cancer of thymus-derived lymphocytes.
    Kaplan J; Mastrangelo R; Peterson WD
    Cancer Res; 1974 Mar; 34(3):521-5. PubMed ID: 4590920
    [No Abstract]   [Full Text] [Related]  

  • 12. [Studies on the subpopulations of peripheral lymphocytes of the patients with idiopathic aplastic anemia (author's transl)].
    Nakata Y; Arimori S; Tada S; Kobashi H
    Rinsho Ketsueki; 1973 Nov; 14(11):1075-9. PubMed ID: 4544620
    [No Abstract]   [Full Text] [Related]  

  • 13. B & T markers in leukemia and lymphoma.
    Bloomfield CD
    Minn Med; 1979 Jul; 62(7):499-501. PubMed ID: 315029
    [No Abstract]   [Full Text] [Related]  

  • 14. Lymphotoxin beta expression is high in chronic lymphocytic leukemia but low in small lymphocytic lymphoma: a quantitative real-time reverse transcriptase polymerase chain reaction analysis.
    Nagy B; Ferrer A; Larramendy ML; Galimberti S; Aalto Y; Casas S; Vilpo J; Ruutu T; Vettenranta K; Franssila K; Knuutila S
    Haematologica; 2003 Jun; 88(6):654-8. PubMed ID: 12801841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of mediastinal mass in acute lymphoblastic leukemia.
    Ravindranath Y; Kaplan J; Zuelzer WW
    Pediatrics; 1975 Jun; 55(6):889-93. PubMed ID: 1094403
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunological cell markers on lymphoblasts of patients with acid phosphatase positive acute leukemia (author's transl)].
    Ritter J; Gaedicke G; Winkler K; Landbeck G
    Z Kinderheilkd; 1975 Sep; 120(3):211-5. PubMed ID: 1080934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The possibilities of optical cytomorphology in differentiating T- and B-lymphocytes (author's transl)].
    Woessner S; Lafuente R
    Sangre (Barc); 1977; 22(5B):814-20. PubMed ID: 303386
    [No Abstract]   [Full Text] [Related]  

  • 18. [Assessment of the immunodeficiency of patients with lymphomata in relapse and in clinical remission (author's transl)].
    Ruibal Ares B; Sasiain M; Brezavscek DM; Suarez A; Bachmann AE
    Sangre (Barc); 1978; 23(5):535-43. PubMed ID: 311077
    [No Abstract]   [Full Text] [Related]  

  • 19. Technical aspects of the rosette technique for detecting human circulating B and T lymphocytes. Normal values and some remarks on null lymphocytes.
    Jonsson V
    Scand J Haematol; 1974; 13(5):361-9. PubMed ID: 4616331
    [No Abstract]   [Full Text] [Related]  

  • 20. Leukemic phase of non-Hodgkin's lymphomas. Hematological features and prognostic significance.
    Morra E; Lazzarino M; Orlandi E; Pagnucco G; Brusamolino E; Castello A; Inverardi D; Bernasconi C
    Haematologica; 1984; 69(1):15-29. PubMed ID: 6428991
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.